These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers. Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536 [TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer. Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599 [TBL] [Abstract][Full Text] [Related]
6. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. How J; Gotlieb WH; Press JZ; Abitbol J; Pelmus M; Ferenczy A; Probst S; Gotlieb R; Brin S; Lau S Gynecol Oncol; 2015 Jun; 137(3):436-42. PubMed ID: 25870917 [TBL] [Abstract][Full Text] [Related]
7. Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer (99m)Tc and/or Blue Dye. Buda A; Crivellaro C; Elisei F; Di Martino G; Guerra L; De Ponti E; Cuzzocrea M; Giuliani D; Sina F; Magni S; Landoni C; Milani R Ann Surg Oncol; 2016 Jul; 23(7):2183-91. PubMed ID: 26714944 [TBL] [Abstract][Full Text] [Related]
8. Indocyanine green versus technetium-99m with blue dye for sentinel lymph node detection in early-stage cervical cancer: A systematic review and meta-analysis. Baeten IGT; Hoogendam JP; Jeremiasse B; Braat AJAT; Veldhuis WB; Jonges GN; Jürgenliemk-Schulz IM; van Gils CH; Zweemer RP; Gerestein CG Cancer Rep (Hoboken); 2022 Jan; 5(1):e1401. PubMed ID: 33973745 [TBL] [Abstract][Full Text] [Related]
9. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874 [TBL] [Abstract][Full Text] [Related]
10. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm). Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944 [TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation. Meads C; Sutton A; Małysiak S; Kowalska M; Zapalska A; Rogozinska E; Baldwin P; Rosenthal A; Ganesan R; Borowiack E; Barton P; Roberts T; Sundar S; Khan K Health Technol Assess; 2013 Dec; 17(60):1-216. PubMed ID: 24331128 [TBL] [Abstract][Full Text] [Related]
13. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study. Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561 [TBL] [Abstract][Full Text] [Related]
14. Sentinel lymphadenectomy in cervical cancer using near infrared fluorescence from indocyanine green combined with technetium-99m-nanocolloid. Soergel P; Kirschke J; Klapdor R; Derlin T; Hillemanns P; Hertel H Lasers Surg Med; 2018 Dec; 50(10):994-1001. PubMed ID: 29968916 [TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937 [TBL] [Abstract][Full Text] [Related]
16. Fluorescent Indocyanine Green versus Technetium-99m and Blue Dye for Bilateral SENTinel Lymph Node Detection in Stage I-IIA Cervical Cancer (FluoreSENT): protocol for a non-inferiority study. Baeten IGT; Hoogendam JP; Braat AJAT; Veldhuis WB; Jonges GN; Jürgenliemk-Schulz IM; Zweemer RP; Gerestein CG BMJ Open; 2022 Sep; 12(9):e061829. PubMed ID: 36100304 [TBL] [Abstract][Full Text] [Related]
17. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial. Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448 [TBL] [Abstract][Full Text] [Related]
18. Combined use of ICG and technetium does not improve sentinel lymph node detection in endometrial cancer: Results of the COMBITEC study. Cabrera S; Barahona-Orpinell M; Almansa-González C; Padilla-Iserte P; Bebia V; Martí L; Tejerizo-García Á; Domingo S; Gil-Moreno A Gynecol Oncol; 2021 Jul; 162(1):32-37. PubMed ID: 33992451 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis]. He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538 [No Abstract] [Full Text] [Related]
20. Sentinel Lymph Node Biopsy in Endometrial Cancer--Comparison of 2 Detection Methods. Sawicki S; Lass P; Wydra D Int J Gynecol Cancer; 2015 Jul; 25(6):1044-50. PubMed ID: 25853384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]